Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 4, 2018
Preserving Preclinical PET Quality During Intratherapeutic Imaging in Radionuclide Therapy with Rose Metal Shielding Reducing Photon Flux
Emma Mellhammar, Magnus Dahlbom, Susan Evans-Axelsson, et al.
Cancer Immunology, Immunotherapy : CII
|
March 31, 2021
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
Kristina Witt, Susan Evans-Axelsson, Andreas Lundqvist, et al.
Seminars in Nuclear Medicine
|
February 22, 2016
Radioimmunotherapy for Prostate Cancer--Current Status and Future Possibilities
Susan Evans-Axelsson, Oskar Vilhelmsson Timmermand, Anders Bjartell, et al.
European Urology
|
July 7, 2015
The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer
Giacomo Canesin, Susan Evans-Axelsson, Rebecka Hellsten, et al.
Journal of Medicinal Chemistry
|
April 26, 2016
Preclinical Characterization of 3β-(N-Acetyl l-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer
Zilma Escobar, Anders Bjartell, Giacomo Canesin, et al.
Plos One
|
September 9, 2017
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
Giacomo Canesin, Susan Evans-Axelsson, Rebecka Hellsten, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
April 23, 2014
Multi-radionuclide digital autoradiography of the intra-aortic atherosclerotic plaques using a monoclonal antibody targeting oxidized low-density lipoprotein
Anders Orbom, Bo Jansson, Alexandru Schiopu, et al.
Nuklearmedizin. Nuclear Medicine
|
March 18, 2025
Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model
Anders Örbom, Susan Evans-Axelsson, Bo Jansson, et al.
British Journal of Pharmacology
|
February 13, 2025
An optimised Bcl-3 inhibitor for melanoma treatment
Karunakar Saamarthy, Renée Daams, Wondossen Sime, et al.
EJNMMI Research
|
June 28, 2015
Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a (111)In-radiolabelled monoclonal antibody, 11B6
Oskar Vilhelmsson Timmermand, David Ulmert, Susan Evans-Axelsson, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 4, 2018
Preserving Preclinical PET Quality During Intratherapeutic Imaging in Radionuclide Therapy with Rose Metal Shielding Reducing Photon Flux
Emma Mellhammar, Magnus Dahlbom, Susan Evans-Axelsson, et al.
Cancer Immunology, Immunotherapy : CII
|
March 31, 2021
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
Kristina Witt, Susan Evans-Axelsson, Andreas Lundqvist, et al.
Seminars in Nuclear Medicine
|
February 22, 2016
Radioimmunotherapy for Prostate Cancer--Current Status and Future Possibilities
Susan Evans-Axelsson, Oskar Vilhelmsson Timmermand, Anders Bjartell, et al.
European Urology
|
July 7, 2015
The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer
Giacomo Canesin, Susan Evans-Axelsson, Rebecka Hellsten, et al.
Journal of Medicinal Chemistry
|
April 26, 2016
Preclinical Characterization of 3β-(N-Acetyl l-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer
Zilma Escobar, Anders Bjartell, Giacomo Canesin, et al.
Plos One
|
September 9, 2017
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
Giacomo Canesin, Susan Evans-Axelsson, Rebecka Hellsten, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
April 23, 2014
Multi-radionuclide digital autoradiography of the intra-aortic atherosclerotic plaques using a monoclonal antibody targeting oxidized low-density lipoprotein
Anders Orbom, Bo Jansson, Alexandru Schiopu, et al.
Nuklearmedizin. Nuclear Medicine
|
March 18, 2025
Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model
Anders Örbom, Susan Evans-Axelsson, Bo Jansson, et al.
British Journal of Pharmacology
|
February 13, 2025
An optimised Bcl-3 inhibitor for melanoma treatment
Karunakar Saamarthy, Renée Daams, Wondossen Sime, et al.
EJNMMI Research
|
June 28, 2015
Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a (111)In-radiolabelled monoclonal antibody, 11B6
Oskar Vilhelmsson Timmermand, David Ulmert, Susan Evans-Axelsson, et al.
Page
of 4